000			01948 a2200493 4500
005			20250513202756.0
264		0	_c20000525
008			200005s 0 0 eng d
022			_a0888-8809
024	7		_a10.1210/mend.14.2.0425 _2doi
040			_aNLM _beng _cNLM
100	1		_aYang, C
245	0	0	_aCalmodulin antagonists inhibit insulin-stimulated GLUT4 (glucose transporter 4) translocation by preventing the formation of phosphatidylinositol 3,4,5-trisphosphate in 3T3L1 adipocytes. _h[electronic resource]
260			_bMolecular endocrinology (Baltimore, Md.) _cFeb 2000
300			_a317-26 p. _bdigital
500			_aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.
650	0	4	_a3T3 Cells _xdrug effects
650	0	4	_aAdipocytes _xdrug effects
650	0	4	_aAnimals
650	0	4	_aCalmodulin _xantagonists & inhibitors
650	0	4	_aGlucose Transporter Type 1
650	0	4	_aGlucose Transporter Type 4
650	0	4	_aInsulin _xmetabolism
650	0	4	_aInsulin Receptor Substrate Proteins
650	0	4	_aMice
650	0	4	_aMonosaccharide Transport Proteins _xdrug effects
650	0	4	_aMuscle Proteins
650	0	4	_aPhosphatidylinositol 3-Kinases _xdrug effects
650	0	4	_aPhosphatidylinositol Phosphates _xmetabolism
650	0	4	_aPhosphoproteins _xmetabolism
650	0	4	_aPhosphorylation
650	0	4	_aPrecipitin Tests
650	0	4	_aProtein Serine-Threonine Kinases
650	0	4	_aProto-Oncogene Proteins _xdrug effects
650	0	4	_aProto-Oncogene Proteins c-akt
650	0	4	_aSulfonamides _xpharmacology
650	0	4	_aTrifluoperazine _xpharmacology
700	1		_aWatson, R T
700	1		_aElmendorf, J S
700	1		_aSacks, D B
700	1		_aPessin, J E
773	0		_tMolecular endocrinology (Baltimore, Md.) _gvol. 14 _gno. 2 _gp. 317-26
856	4	0	_uhttps://doi.org/10.1210/mend.14.2.0425 _zAvailable from publisher's website
999			_c10628787 _d10628787